Nicotine transdermal system step 2 14 mg/24h
Nicotine · PATCH, EXTENDED RELEASE · The Kroger Co.
Nicotine Transdermal System Step 2 is a skin patch that delivers nicotine over 24 hours to help reduce cravings and withdrawal symptoms when quitting smoking. This is typically used as a second step in a graduated nicotine replacement therapy program.
Key Facts
- Brand Name
- Nicotine transdermal system step 2
- Generic Name
- Nicotine
- NDC Code (Product)
59450-002- Manufacturer
- The Kroger Co.
- Strength
- 14 mg/24h
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- Application #
- NDA020076
- Drug Class
- Cholinergic Nicotinic Agonist [EPC]
- Marketing Start
- 08/25/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Nicotine transdermal system step 2 used for?
Nicotine Transdermal System Step 2 is a skin patch that delivers nicotine over 24 hours to help reduce cravings and withdrawal symptoms when quitting smoking. This is typically used as a second step in a graduated nicotine replacement therapy program.
Is Nicotine transdermal system step 2 a controlled substance?
Nicotine transdermal system step 2 is not classified as a controlled substance by the DEA.
What is the generic name for Nicotine transdermal system step 2?
The generic name for Nicotine transdermal system step 2 is Nicotine. There are 12 other brand versions of Nicotine.
What is the NDC code for Nicotine transdermal system step 2 14 mg/24h?
The NDC (National Drug Code) for Nicotine transdermal system step 2 14 mg/24h is 59450-002, listed by The Kroger Co..
Other Nicotine Brands
See all →- Nicotine Polacrilex4 mg/172162-2288
- Nicotine4 mg/172224-930
- Basic Care Nicotine4 mg/172288-003
- basic care nicotine2 mg/172288-206
- basic care nicotine4 mg/172288-532
- AMAZON BASIC CARE NICOTINE POLACRILEX4 mg/172288-690
- Habitrol Nicotine Polacrilex Gum 4 mg Coated Mint4 mg/175907-303
- topcare nicotine4 mg/176162-700
- nicotine4 mg/179481-1100
- BLIP4 mg/182966-303
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)